ALAN G GASNER MD NPI 1225006638

NPI Details

Alan G Gasner, MD is an internal medicine in Winter Haven, FL. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Alan G Gasner, MD NPI is 1225006638. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

635 1ST ST N
WINTER HAVEN, FL
ZIP 33881-129
Phone: (863) 294-0670
Fax: (863) 298-3200

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, denosumab, 1 mg (HCPCS:J0897)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Hemoglobin a1c level (HCPCS:83036)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Bacterial colony count, urine (HCPCS:87086)
• Vitamin d-3 level (HCPCS:82306)
• Blood test, clotting time (HCPCS:85610)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• X-ray of chest, 2 views (HCPCS:71046)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Screening 3d breast mammography (HCPCS:77063)
• Screening mammography (HCPCS:77067)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Urine microalbumin (protein) level (HCPCS:82043)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Coronavirus vaccine 14 (HCPCS:91313)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Technetium tc-99m sestamibi, diagnostic, per study dose (HCPCS:A9500)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Folic acid level, serum (HCPCS:82746)
• Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
• Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician (HCPCS:93015)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Uric acid level, blood (HCPCS:84550)
• Sarscov2 vac 50mcg/0.25ml im (HCPCS:91306)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Nuclear medicine studies of heart muscle at rest and with stress and spect (HCPCS:78452)
• Kidney function blood test panel (HCPCS:80069)
• X-ray of hip, 2-3 views (HCPCS:73502)
• Ldl cholesterol level (HCPCS:83721)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Ct scan of chest without contrast (HCPCS:71250)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Electrocardiogram (ecg) 2-day continuous (HCPCS:93225)
• Electrocardiogram (ecg) 2-day continuous with report (HCPCS:93226)
• Electrocardiogram (ecg) 2-day continuous with review by health care professional (HCPCS:93227)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Screening test for autoimmune disorder (HCPCS:86038)
• Rheumatoid factor level (HCPCS:86431)

The enumeration date for this NPI number is 3/10/2006 and was last updated on 5/20/2008.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.